Payers

CMAP™ utilization has established itself as the GO-TO soft tissue injury test, providing 15-20% reductions in medical and indemnity claims cost, improved claim closure rates and reductions in reserves set aside for claims management, employers, third party administrators and insurance companies.

CMAP benefits payers
  • Reducing medical and indemnity costs as related to soft tissue injuries.
  • Closing claims more quickly while ensuring patients have been diagnosed and treated properly for their injuries.
  • Providing the ability to more precisely set reserves for soft tissue injury claims.
  • Assisting the return of the patient to health and work more quickly.

MED-TEK is confident that its greatest value lies in its unique ability to provide physicians with CMAP™ generated data that heretofore was not available. This data can then be used by physicians in AOE/COE determinations, clinical diagnosis and P&S determinations. CMAP™ is a provider of objective data that complements a physician’s clinical experience. CMAP™ has been validated in assisting in cases where results from other modalities have not provided sufficient objective data to develop a diagnosis and subsequent treatment plan. CMAP™ provides unparalleled value when socio-psychological issues make medical evaluations and subsequent decisions difficult based on subjective complaints, as opposed to reliance on proven objective data.

MED-TEK recently completed a three year campaign with the primary goals to introduce, create utilization and quantify results from CMAP™ testing to empirically demonstrate to employers, TPAs and insurance companies the ability of CMAP™ to objectively and accurately quantify the veracity, location and severity of soft tissue injuries. In addition, MED-TEK subjected CMAP™ to clinical trials and independent retrospective analysis. Results have been published in occupational health peer reviewed journals: Journal of Occupational Rehabilitation Q’1 2009, Practical Pain Management, March 2009 and a retrospective analysis accepted for publication in the Journal of Applied Biobehavioral Research Q’3 2009. These positive results have enabled CMAP™ to gain acceptance and traction with the medical community.

The most cost-efficient way for claim payers to improve clinical and financial outcomes of soft tissue injury claims is by ensuring that the truly injured worker returns more rapidly to health and work. This is much more likely to be accomplished through an early, accurate and precise diagnosis.

Independent statistical analysis has demonstrated that utilization of CMAP™ suite of evaluations has provided clear improvement in clinical outcome.